基本信息 产品详情 公司简介 推荐产品
网站主页 Sorafenib Tosylate Intermediates
  • Sorafenib Tosylate Intermediates

Sorafenib Tosylate Intermediates

Sorafenib Tosylate Intermediates
河北 更新日期:2024-11-13

Shijiazhuang Dingmin Pharmaceutical Sciences Co., Ltd.

VIP1年
联系人:CandyWang
电话:+86-0311-67591193拨打
手机:+8613931880626 拨打
邮箱:sales02@dingminpharma.com

产品详情:

中文名称:
Sorafenib Tosylate Intermediates
英文名称:
Sorafenib Tosylate Intermediates
CAS号:
013

Sorafenib tosylate



Sorafenib tosylate
Cas No.:
 475207-59-1
Appearance: White to light yellow powder
Formula: C14H18N2O5
Molecular: 294.30
Structure:
               
Purity: ≥99%
Usage: Pharmaceutical intermediates, anti-cancer drugs

Shijiazhuang Dingmin Pharmaceutical Sciences Co., Limited is a professional company ocusing on the R&D, production, marketing and technical service of APIs and pharmaceutical intermediates. We have a R&D center and two plants in Shijiazhuang, Hebei Province. Our Products include active pharmaceutical ingredients (API), pharmaceutical and agrochemical intermediates and chiral compounds. We have won the trust of a wide range of customers/partners in the industry. Our major products are antineoplastic, cardiovascular and antibiotics and their intermediates.


In order to maintain continuous innovation and R & D capability, we maintain long-term and close cooperation with many research institutions and universities, Our co-production plants are located in Anhui, Jiangsu, Zhejiang and Inner Mongolia. The products have been sold to Europe, America, Southeast Asia and other countries and regions


Having upholding the " integrity, profession , innovation, win-win" as business philosophy, we believe that we are able to be stronger and stronger because of the excellent quality, favorable price and full-hearted service. We would like to sincerely welcome friends from all sectors to co-create a brilliant tomorrow together.

Sorofenib Intermediates;Intermediates;Sorafenib Tosylate Intermediates

成立日期 (11年)
注册资本 100万人民币
员工人数 10-50人
年营业额 ¥ 5000万-1亿
经营模式 贸易,工厂
主营行业 中间体,医药原料

Sorafenib Tosylate Intermediates相关厂家报价

内容声明
拨打电话 立即询价